In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

We use cookies to optimise the design of this website and make continuous improvement. By continuing your visit, you consent to the use of cookies. Learn more


ESC Working Group on Cardiovascular Pharmacotherapy

Nucleus 2014-2016


Prof. Stefan Agewall, FESC
Department Of Cardiology
Oslo Uni Hospital Ulleval
Kirkeveien 166
Ulleval sykehus
0424 Oslo - Norway


Prof.  Basil S. Lewis, FESC
Cardiovascular Clinical Research Institute
Lady Davis Carmel Medical Center
7 Michal Street
IL-34362 Haifa - Israel
Tel: +972 4 82 0803, email


Prof. Keld Per Kjeldsen
Rigshospitalet and Aalborg University,
The Heart Centre 2142,
Rigshospitalet, Blegdamsvej 9,
2100 Copenhagen - Denmark
Tel: +45 40 25 37 84, email


Prof. Christian T. Torp-Pedersen, FESC
Health Science And Technology
Aalborg University
Niels Jernes Vej 12, A5-208
9220 Aalborg, Denmark
Tel: +45 9940 3802, email


Prof. Claudio Ceconi, FESC (IT), email
Prof. Heinz Drexel, FESC (AT),email
Prof. Christian Funck-Brentano, FESC (FR), email
Prof. Juan Carlos Kaski, FESC (UK), email
Assoc. Prof. Alexander Niessner, (AT), email
Prof. Juan Tamargo, FESC (ES), email
Prof. Thomas Walther, FESC (DE), email


Prof.  Dan Atar, FESC (NO),email
Dr. Maria Angeles Alonso Garcia, FESC (ES), email
Prof. Faiez Zannad, FESC (FR),email


Assoc. Prof.  Sven Wassmann, FESC, email
Prof.  Giuseppe M.C. Rosano, FESC, email
Prof.  Harald Schmidt, FESC, email

Aims & Activities


  • To promote and organize research in the field of cardiovascular pharmacology and drug therapy
  • To design and coordinate scientific research in its specialty
  • To be involved in task forces of the European Society of Cardiology related to cardiovascular pharmacology
  • To increase the number of WG members


  • To start up and strengthen the new journal of the working group, entitled European Heart Journal-Cardiovascular Pharmacotherapy. The journal will come out with 4 issues during 2015 aiming at increasing that number up to 12 issues a year within 5-6 years. An aim with the journal is to become the strongest scientific journal within cardiovascular pharmacology
  • To organize yearly scientific meeting of the WG with focus on cardiovascular pharmacology
  • To participate in the production of ESC practical guidelines
  • To publish position papers within the area of the working group
  • To contribute to the organisation and preparation of the Annual Congress of the ESC
  • To participate and support other scientific meetings and symposia
  • To organise teaching workshops and other types of education on topics related to cardiovascular pharmacology and drug therapy
  • To hold regular meetings of the nucleus of the working Group




Back to top